NIH

David Cortez, Ph.D., and his Vanderbilt colleagues report new findings that shed light on fundamental processes involved in DNA replication and have implications for cancer therapies that target these processes. Read More

With the help of computerized eye trackers, new research finds that at least 50 percent of people can see the movement of their own hand even in the absence of all light. Read More

Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB. Read More

A non-invasive measure of electrical brain activity in preterm infants predicts cognitive and communication functioning during early childhood, according to a new Vanderbilt University study. Read More

Vanderbilt researchers have identified a key regulator of cell division. Read More

Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness. Read More

A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions. Read More

In the latest VUCast: ICU patients are leaving hospitals with a dementia-like disease; What’s the fate of the Republican Party?; Hear from Pulitzer Prize-winning author and Distinguished Visiting Professor Jon Meacham; and It's time to celebrate -- the Rate My Professor 2013 rankings are in. All this and more in Vanderbilt’s online newscast. Watch now. Read More

The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance. Read More

Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer. Read More

Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases. Read More

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. Read More

Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine. Read More

Neuroscientists have identified the location in the brain's visual cortex responsible for generating a common perceptual illusion: seeing shapes and surfaces that don't really exist when viewing a fragmented background. Read More

Vanderbilt researchers used existing genome-wide association study datasets to identify gene interactions that contribute to tooth decay. Read More

A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis. Read More

Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer. Read More

The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units. Read More

Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring. Read More

Researchers work to prevent possible bird flu pandemic How stars solve mysteries of the universe And conquering the video gaming industry Vandy style? All this and more in this week’s VUCast, Vanderbilt’s online newscast. Watch now. [vucastblurb]… Read More